ELI LILLY & Co is 6.9x more valuable than ABBOTT LABORATORIES by market capitalization ($1.070 T vs $155.32 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABT | LLY |
|---|---|---|
| Market cap | $155.32 B | $1.070 T |
| US-listed rank | #94 | #10 |
| Revenue (latest FY) | $44.33B | $65.18B |
| Net income (latest FY) | $6.52B | $20.64B |
| Net margin | 14.7% | 31.7% |
| P/E (trailing FY) | 23.8 | 51.8 |
| SEC filings | 1,001 | 989 |
ELI LILLY & Co is 6.9x more valuable than ABBOTT LABORATORIES by market capitalization ($1.070 T vs $155.32 B).
In their latest fiscal years, ABBOTT LABORATORIES reported $44.33B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ABBOTT LABORATORIES and ELI LILLY & Co, or browse the full rankings.